Proceedings of the National Academy of Sciences · 2000 · 620 citations · 28 references
PharmacyBiochemistryMolecular BiologyGene ExpressionNucleic Acid BiochemistryNucleic Acid ChemistryNucleic Acid DeliveryNucleic Acid Drug DesignOligonucleotide ChemistryOligonucleotide DeliveryRibonucleic Acid (Rna) ChemistryRna InterferenceAntisense RnasNucleic Acid TherapeuticsNucleotide AnalogsOligonucleotide TherapeuticsPhosphorothioate Chemistry
Insufficient efficacy and/or specificity of antisense oligonucleotides limit their in vivo usefulness. We demonstrate here that a high-affinity DNA analog, locked nucleic acid (LNA), confers several desired properties to antisense agents. Unlike DNA, LNA/DNA copolymers were not degraded readily in blood serum and cell extracts. However, like DNA, the LNA/DNA copolymers were capable of activating RNase H, an important antisense mechanism of action. In contrast to phosphorothioate-containing oligonucleotides, isosequential LNA analogs did not cause detectable toxic reactions in rat brain. LNA/DNA copolymers exhibited potent antisense activity on assay systems as disparate as a G-protein-coupled receptor in living rat brain and an Escherichia coli reporter gene. LNA-containing oligonucleotides will likely be useful for many antisense applications.
28